Connect with us

Health

New evidence shows microbe strain can orally treat systemic inflammation in psoriasis – Science Codex

Published

on

LUGANO, 29 October, 2020 – Disruptive innovations in psoriasis are leading the way at EADV’s 29th Congress, EADV Virtual. New data published today shows the first clinical evidence of modulating systemic inflammation by oral delivery of a non-living single strain commensal microbe. This new therapeutic class brings hope for a completely new way of treating this debilitating skin condition (1).
The phase 1b clinical study, by Evelo Biosciences, evaluated EDP1815, a preparation of a non-living single…

Click here to view the original article.

Continue Reading
Advertisement
Advertisement

Trending